Veeva Systems announced today that Novartis Pharmaceuticals AG, a world leader in the research, development, manufacturing and marketing of products to protect and improve health and well-being, has chosen Veeva CRM® for various global deployments.
“We are thrilled to take our Novartis relationship global”
Over the past three years, Veeva has quickly become a leading provider of Pharma CRM systems globally. Because of its multi-tenant SaaS architecture, Veeva CRM requires no hardware or software to purchase, scale, or maintain. In addition, all Veeva customers benefit from free, automatic upgrades so users are always on the latest version of the software with the very latest compliance changes and system enhancements.
"We are thrilled to take our Novartis relationship global," said Peter Gassner, president and CEO of Veeva Systems.
New research sheds light on how GLP-1 obesity drugs may change food cravings